OpenAlex
PricingAboutJobs
Log inGet started
Work

Characterization of MK-4166, a Clinical Agonistic Antibody That Targets Human GITR and Inhibits the Generation and Suppressive Effects of T Regulatory Cells

HTML

Year: 2017
Type: article
Source: Cancer Research
DOI: 10.1158/0008-5472.can-16-1439
Authors: Selvakumar Sukumar, Douglas C. Wilson, Ying Yu, Jerelyn Wong, Saraswathi Naravula, Grigori Ermakov, Romina Riener, Bhagyashree Bhagwat, Antoaneta S. Necheva, Jeff Grein, Tatyana Churakova, Ruban Mangadu, Peter Georgiev, Denise Manfra, Elaine M. Pinheiro, Venkataraman Sriram, Wendy J. Bailey, Danuta Herzyk, Terrill K. McClanahan, Aarron Willingham, Amy M. Beebe, Svetlana Sadekova
Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)
Language: English

Topic: T-cell and B-cell Immunology
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: GITR, agonistic antibodies, regulatory T cells, tumor-infiltrating lymphocytes, NF-κB signaling, DUSP6, ERK signaling, Foxp3, tumor microenvironment, antitumor immunity, humanized monoclonal antibody
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2626962960
FWCI: 2.683
Cites: 43
Cited by: 67
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security